1. Home
  2. MNDO vs ITRM Comparison

MNDO vs ITRM Comparison

Compare MNDO & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.16

Market Cap

24.2M

Sector

Technology

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.30

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDO
ITRM
Founded
1995
2015
Country
Israel
Ireland
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.2M
24.3M
IPO Year
2000
2018

Fundamental Metrics

Financial Performance
Metric
MNDO
ITRM
Price
$1.16
$0.30
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.00
AVG Volume (30 Days)
26.1K
398.6K
Earning Date
03-03-2026
03-20-2026
Dividend Yield
19.30%
N/A
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$19,770,000.00
$390,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$947.65
P/E Ratio
$8.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.26
52 Week High
$2.13
$1.58

Technical Indicators

Market Signals
Indicator
MNDO
ITRM
Relative Strength Index (RSI) 40.69 42.28
Support Level $1.19 $0.27
Resistance Level $1.25 $0.37
Average True Range (ATR) 0.05 0.03
MACD -0.01 0.00
Stochastic Oscillator 0.09 24.20

Price Performance

Historical Comparison
MNDO
ITRM

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: